Broad spectrum antimicrobial PDMS-based biomaterial for catheter fabrication
Source abstract
Abstract
Abstract Background In addition to the widespread use of antibiotics in healthcare settings, the current COVID-19 pandemic has escalated the emergence of antibiotic resistance. Nosocomial infections among hospitalized patients is a leading site for such resistant microbial colonization due to prolonged use of invasive devices and antibiotics in therapies. Invasive medical devices, especially catheters, are prone to infections that could accelerate the development of resistant microbes. Often, catheters - particularly urinary catheters - are prone to high infection rates. Antibiotic-coated catheters can reduce infection rates and although commercially available, are limited in efficacy and choices. Methods Herein, a novel and facile method to fabricate PMDS-based biomaterial for the development of antimicrobial eluting catheters is presented. Silicone based organic polymer polydimethylsiloxane (PDMS) was used to prepare a biomaterial containing novel polymeric imidazolium antimicrobial compound. Results It was found that the PDMS-based biomaterials could eradicate microbial colonization even after 60 days in culture with continuous microbial challenge, be recycled over multiple uses, stored at room temperature for long-term usage and importantly is biocompatible. Conclusion The PDMS-based biomaterial displayed biocidal functionality on microbes of clinical origin, which form major threats in hospital acquired infections. Graphical Abstract
Source: crossref · Quality: baseline
Research context
OpenAlex topics: Antimicrobial agents and applications · Urinary Tract Infections Management · Infectious Aortic and Vascular Conditions
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (45)
Show source-provided references
1. Knight GM, Glover RE, McQuaid CF, Olaru ID, Gallandat K, Leclerc QJ, et al. Antimicrobial resistance and COVID-19: intersections and implications. eLife. 2021;10:e64139. https://doi.org/10.7554/eLife.64139.10.7554/eLife.64139 ↗
2. Pelfrene E, Botgros R, Cavaleri M. Antimicrobial multidrug resistance in the era of COVID-19: a forgotten plight? Antimicrob Resist Infect Control. 2021;10(1):21. https://doi.org/10.1186/s13756-021-00893-z.10.1186/s13756-021-00893-z ↗
3. Weiner LM, Webb AK, Limbago B, Dudeck MA, Patel J, Kallen AJ, et al. Antimicrobial-resistant pathogens associated with healthcare-associated infections: summary of data reported to the national healthcare safety network at the centers for disease control and prevention, 2011-2014. Infect Control Hosp Epidemiol. 2016;37(11):1288–301. https://doi.org/10.1017/ice.2016.174.10.1017/ice.2016.174 ↗
4. Andersen MJ, Flores-Mireles AL. Urinary catheter coating modifications: the race against catheter-associated infections. Coatings. 2020;10(1):23. https://doi.org/10.3390/coatings10010023.10.3390/coatings10010023 ↗
5. Ahonen M, Kahru A, Ivask A, Kasemets K, Kõljalg S, Mantecca P, et al. Proactive approach for safe use of antimicrobial coatings in healthcare settings: opinion of the COST action network AMiCI. Int J Environ Res Public Health. 2017;14(4):366. https://doi.org/10.3390/ijerph14040366.10.3390/ijerph14040366 ↗
6. Riley DK, Classen DC, Stevens LE, Burke JP. A large randomized clinical trial of a silver-impregnated urinary catheter: lack of efficacy and staphylococcal superinfection. Am J Med. 1995;98(4):349–56. https://doi.org/10.1016/S0002-9343(99)80313-1.10.1016/S0002-9343(99)80313-1 ↗
7. Srinivasan A, Karchmer T, Richards A, Song X, Perl TM. A prospective trial of a novel, silicone-based, silver-coated Foley catheter for the prevention of nosocomial urinary tract infections. Infect Control Hosp Epidemiol. 2006;27(1):38–43. https://doi.org/10.1086/499998.10.1086/499998 ↗
8. Menezes FG, Correa L, Medina-Pestana JO, Aguiar WF, Camargo LFA. A randomized clinical trial comparing Nitrofurazone-coated and uncoated urinary catheters in kidney transplant recipients: results from a pilot study. Transpl Infect Dis. 2019;21(2):e13031. https://doi.org/10.1111/tid.13031.10.1111/tid.13031 ↗
9. Hodgkinson V, Petris MJ. Copper homeostasis at the host-pathogen interface. J Biol Chem. 2012;287(17):13549–55. https://doi.org/10.1074/jbc.R111.316406.10.1074/jbc.R111.316406 ↗
10. Zhu Z, Wang Z, Li S, Yuan X. Antimicrobial strategies for urinary catheters. J Biomed Mater Res A. 2019;107(2):445–67. https://doi.org/10.1002/jbm.a.36561.10.1002/jbm.a.36561 ↗
11. Zhang J, Chen Y, Brook MA. Facile functionalization of PDMS elastomer surfaces using thiol-ene click chemistry. Langmuir. 2013;29(40):12432–42. https://doi.org/10.1021/la403425d.10.1021/la403425d ↗
12. Milo S, Thet NT, Liu D, Nzakizwanayo J, Jones BV, Jenkins ATA. An in-situ infection detection sensor coating for urinary catheters. Biosens Bioelectron. 2016;81:166–72. https://doi.org/10.1016/j.bios.2016.02.059.10.1016/j.bios.2016.02.059 ↗
13. Bayston R, Fisher LE, Weber K. An antimicrobial modified silicone peritoneal catheter with activity against both gram-positive and gram-negative bacteria. Biomaterials. 2009;30(18):3167–73. https://doi.org/10.1016/j.biomaterials.2009.02.028.10.1016/j.biomaterials.2009.02.028 ↗
14. Fisher LE, Hook AL, Ashraf W, Yousef A, Barrett DA, Scurr DJ, et al. Biomaterial modification of urinary catheters with antimicrobials to give long-term broadspectrum antibiofilm activity. J Control Release. 2015;202:57–64. https://doi.org/10.1016/j.jconrel.2015.01.037.10.1016/j.jconrel.2015.01.037 ↗
15. Thomé IPS, Dagostin VS, Piletti R, Pich CT, Riella HG, Angioletto E, et al. Bactericidal low density polyethylene (LDPE) urinary catheters: microbiological characterization and effectiveness. Mater Sci Eng C. 2012;32(2):263–8. https://doi.org/10.1016/j.msec.2011.10.027.10.1016/j.msec.2011.10.027 ↗
16. Anjum S, Gupta B. Bioengineering of functional nanosilver nanogels for smart healthcare systems. Glob Chall. 2018;40(10):1800044. https://doi.org/10.1002/gch2.201800044.10.1002/gch2.201800044 ↗
17. Lim K, Chua RR, Bow H, Tambyah PA, Hadinoto K, Leong SS. Development of a catheter functionalized by a polydopamine peptide coating with antimicrobial and antibiofilm properties. Acta Biomater. 2015;15:127–38. https://doi.org/10.1016/j.actbio.2014.12.015.10.1016/j.actbio.2014.12.015 ↗
18. Lim K, Saravanan R, Chong KKL, Goh SHM, Chua RRY, Tambyah PA, et al. Anhydrous polymer-based coating with sustainable controlled release functionality for facile, efficacious impregnation, and delivery of antimicrobial peptides. Biotechnol Bioeng. 2018;115(8):2000–12. https://doi.org/10.1002/bit.26713.10.1002/bit.26713 ↗
19. Liu L, Wu H, Riduan SN, Ying JY, Zhang Y. Short imidazolium chains effectively clear fungal biofilm in keratitis treatment. Biomaterials. 2013;34(4):1018–23. https://doi.org/10.1016/j.biomaterials.2012.10.050.10.1016/j.biomaterials.2012.10.050 ↗
20. Liu L, Huang Y, Riduan SN, Gao S, Yang Y, Fan W, et al. Main-chain imidazolium oligomer material as a selective biomimetic antimicrobial agent. Biomaterials. 2012;33(33):8625–31. https://doi.org/10.1016/j.biomaterials.2012.08.006.10.1016/j.biomaterials.2012.08.006 ↗
21. Salernitano E, Migliaresi C. Composite materials for biomedical applications: a review. J Appl Biomater Biomech. 2003;1(1):3–18.
22. Malcolm RK, McCullagh SD, Woolfson AD, Gorman SP, Jones DS, Cuddy J. Controlled release of a model antibacterial drug from a novel self-lubricating silicone biomaterial. J Control Release. 2004;97(2):313–20. https://doi.org/10.1016/j.jconrel.2004.03.029.10.1016/j.jconrel.2004.03.029 ↗
23. Japanese Industrial Standard JIS Z 2801. Test for antibacterial activity and efficacy. www.jsa.or.jp. Japanese Standards Association. Tokyo. Japan. 2010.
24. Merritt JH, Kadouri DE, O'Toole GA. Growing and analyzing static biofilms. Curr Protoc Microbiol. 2005;Chapter 1:Unit 1B.1. https://doi.org/10.1002/9780471729259.mc01b01s00.10.1002/9780471729259.mc01b01s00 ↗
25. Mandakhalikar KD, Rahmat JN, Chiong E, Neoh KG, Shen L, Tambyah PA. Extraction and quantification of biofilm bacteria: method optimized for urinary catheters. Sci Rep. 2018;8(1):8069. https://doi.org/10.1038/s41598-018-26342-3.10.1038/s41598-018-26342-3 ↗
26. Zhang S, Wang L, Liang X, Vorstius J, Keatch R, Corner G, et al. Enhanced antibacterial and anti-adhesive activities of silver−PTFE nanocomposite coating for urinary catheters. ACS Biomater Sci Eng. 2019;5(6):2804–14. https://doi.org/10.1021/acsbiomaterials.9b00071.10.1021/acsbiomaterials.9b00071 ↗
27. Chamsaz EA, Mankoci S, Barton HA, Joy A. Nontoxic cationic coumarin polyester coatings prevent pseudomonas aeruginosa biofilm formation. ACS Appl Mater Interfaces. 2017;9(8):6704–11. https://doi.org/10.1021/acsami.6b12610.10.1021/acsami.6b12610 ↗
28. Pendleton JN, Gorman SP, Gilmore BF. Clinical relevance of the ESKAPE pathogens. Expert Rev Anti-Infect Ther. 2013;11(3):297–308. https://doi.org/10.1586/eri.13.12.10.1586/eri.13.12 ↗
29. Liu K, Shen X, Bai S, Conrad Zhang ZC. Stable discrete Pt (0) in crown ether with ultra-high hydrosilylation activity. ChemCatChem. 2020;12(1):267–72. https://doi.org/10.1002/cctc.201901577.10.1002/cctc.201901577 ↗
30. Zhou C, Wu Y, Thappeta KRV, Subramanian JTL, Pranantyo D, Kang ET, et al. In vivo anti-biofilm and anti-bacterial non-leachable coating thermally polymerized on cylindrical catheter. ACS Appl Mater Interfaces. 2017;9(41):36269–80. https://doi.org/10.1021/acsami.7b07053.10.1021/acsami.7b07053 ↗
31. Cruz-Félix AS, Santiago-Alvarado A, Márquez-García J, González-García J. PDMS samples characterization with variations of synthesis parameters for tunable optics applications. Heliyon. 2019;5(12):e03064. https://doi.org/10.1016/j.heliyon.2019.e03064.10.1016/j.heliyon.2019.e03064 ↗
32. Mulani MS, Kamble EE, Kumkar SN, Tawre MS, Pardesi KR. Emerging strategies to combat ESKAPE pathogens in the era of antimicrobial resistance: a review. Front Microbiol. 2019;10:539. https://doi.org/10.3389/fmicb.2019.00539.10.3389/fmicb.2019.00539 ↗
33. Ricardo SIC, Anjos IIL, Monge N, Faustino CMC, Ribeiro IAC. A glance at antimicrobial strategies to prevent catheter-associated medical infections. ACS Infect Dis. 2020;6(12):3109–30. https://doi.org/10.1021/acsinfecdis.0c00526.10.1021/acsinfecdis.0c00526 ↗
34. Francolini I, Vuotto C, Piozzi A, Donelli G. Antifouling and antimicrobial biomaterials: an overview. APMIS. 2017;125(4):392–417. https://doi.org/10.1111/apm.12675.10.1111/apm.12675 ↗
35. Dave RN, Joshi HM, Venugopalan VP. Novel biocatalytic polymer-based antimicrobial coatings as potential ureteral biomaterial: preparation and in vitro performance evaluation. Antimicrob Agents Chemother. 2011;55(2):845–53. https://doi.org/10.1128/AAC.00477-10.10.1128/AAC.00477-10 ↗
36. Liu H, Shukla S, Vera-González N, Tharmalingam N, Mylonakis E, Fuchs BB, et al. Auranofin releasing antibacterial and antibiofilm polyurethane intravascular catheter coatings. Front Cell Infect Microbiol. 2019;9:37. https://doi.org/10.3389/fcimb.2019.00037.10.3389/fcimb.2019.00037 ↗
37. Schierholz JM, Steinhauser H, Rump AF, Berkels R, Pulverer G. Controlled release of antibiotics from biomedical polyurethanes: morphological and structural features. Biomaterials. 1997;18(12):839–44. https://doi.org/10.1016/S0142-9612(96)00199-8.10.1016/S0142-9612(96)00199-8 ↗
38. Riool M, de Breij A, Drijfhout JW, Nibbering PH, Zaat SAJ. Antimicrobial peptides in biomedical device manufacturing. Front Chem. 2017;5:63. https://doi.org/10.3389/fchem.2017.00063.10.3389/fchem.2017.00063 ↗
39. Wu P, Grainger DW. Drug/device combinations for local drug therapies and infection prophylaxis. Biomaterials. 2006;27(11):2450–67. https://doi.org/10.1016/j.biomaterials.10.1016/j.biomaterials ↗
40. Sievert DM, Ricks P, Edwards JR, Schneider A, Patel J, Srinivasan A, et al. National Healthcare Safety Network (NHSN) team and participating NHSN facilities. Antimicrobial-resistant pathogens associated with healthcare-associated infections: summary of data reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2009-2010. Infect Control Hosp Epidemiol. 2013;34(1):1–14. https://doi.org/10.1086/668770.10.1086/668770 ↗
41. Si Z, Lim HW, Tay MYF, Du Y, Ruan L, Qiu H, et al. A glycosylated cationic block poly(β-peptide) reverses intrinsic antibiotic resistance in all ESKAPE gram-negative bacteria. Angew Chem Int Ed. 2020;59(17):6819–26. https://doi.org/10.1002/anie.201914304.10.1002/anie.201914304 ↗
42. Wu B, Yang X, Yan M. Synthesis and structure-activity relationship study of antimicrobial auranofin against ESKAPE pathogens. J Med Chem. 2019;62(17):7751–68. https://doi.org/10.1021/acs.jmedchem.9b00550.10.1021/acs.jmedchem.9b00550 ↗
43. Lin Q, Deslouches B, Montelaro RC, Di YP. Prevention of ESKAPE pathogen biofilm formation by antimicrobial peptides WLBU2 and LL37. Int J Antimicrob Agents. 2018;52(5):667–72. https://doi.org/10.1016/j.ijantimicag.2018.04.019.10.1016/j.ijantimicag.2018.04.019 ↗
44. Lam SJ, O'Brien-Simpson NM, Pantarat N, Sulistio A, Wong EH, Chen YY, et al. Combating multidrug-resistant gram-negative bacteria with structurally nanoengineered antimicrobial peptide polymers. Nat Microbiol. 2016;1(11):16162. https://doi.org/10.1038/nmicrobiol.2016.162.10.1038/nmicrobiol.2016.162 ↗
45. Hall T, Villapun V, Addison O, Webber M, Lowther M, Louth S, et al. A call for action to the biomaterial community to tackle antimicrobial resistance. Biomaterials Science. 2020;8(18):4951–74. https://doi.org/10.1039/D0BM01160F.10.1039/D0BM01160F ↗